BioIndustry Association Broadens Business Solutions Program to Offer Further Savings for Members
Published: Sep 20, 2012
The BIA launched its business solutions programme in June offering members cost savings on laboratory supplies from VWR International. The business solutions programme leverages the purchasing power of over 2,700 organisations through the US-based Biotechnology Industry Organization (BIO) for both BIA members and UK-based members of BIO.
Kevin McNeil, purchasing manager for ImmunoGen, a mid-sized biotech company located in Waltham, Massachusetts, said:
"The Office Depot program that is offered by BIO in the States provides exceptional value. We took a close look at the many office supply provider options that were available to us and the BIO-Office Depot program offered the most benefits and overall value, including the best pricing. The decision of which provider to go with was an easy one."
Steve Bates, BIA Chief Executive Officer, said:
"The addition of another service provider to our business solutions programme demonstrates the BIA's dedication to ensuring our members are able to access significant savings on the products and services they use in their day-to-day operations.
"The savings generated by using our business solutions programme should more than offset the BIA membership fee for the biotech SMEs with fewer than 20 staff that form our core membership."
For further information, please contact Robert Winder, Head of Communications, firstname.lastname@example.org, 020 7630 2191; mobile 07825 942 934.
BIA business solutions programme http://bit.ly/biabusiness
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org